Regeneus Ltd (ASX: RGS) merged with Cambium Medical Technologies creating Cambium Bio Limited (ASX:CMB), focusing on dry eye and ophthalmology. For more information about the Company and its programs, please visit www.cambium.bio
Headquarter Australia |
Countries of operation Australia |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
CFO / COO
Head of CMC and R&D
Chief Scientific Officer
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
CFO / COO | hidden.item | hidden.item | hidden.item | |||
Head of CMC and R&D | hidden.item | hidden.item | hidden.item | |||
Chief Scientific Officer | hidden.item | hidden.item | hidden.item |